Can a new breathing device help people in hospital with severe flare ups of chronic lung disease clear mucus and breathe more easily?

Feasibility and benefits of an oscillatory negative-pressure device for secretion mobilization in patients hospitalized with acute COPD exacerbation - a randomized controlled trial

Registry ID
ISRCTN58374348
Source registry
ISRCTN
Status
Recruiting
Phase
PHASE1_PHASE2
Study type
INTERVENTIONAL
Sponsor
Unidade Local de Saude do Alto Ave
Enrollment
80
Start date
2024-11-01
Completion date
2026-12-31
Last update
2026-08-17

Conditions

Summary

Patients hospitalized with acute exacerbation of COPD

Detailed description

Participants will be recruited by the attending physician in collaboration with a physiatrist, who confirmed the indication for respiratory rehabilitation. An initial interview will be conducted by one of the investigators to verify eligibility criteria and obtain written informed consent. After consent is obtained, the baseline assessment (Assessment 0) will be performed and recorded in the Case Report Form. In this first assessment, demographic data, clinical history and clinical evaluation (Vital signs, respiratory simptoms, CAT, Leicester acute) will be registered. Participants will then be randomized to either the intervention group or the control group using appropriate randomization software (Randomizer®) making a computer-generated allocation sequence. The control group will receive conventional respiratory physiotherapy (breathing retraining, controlled inspiratory slow breathing, Slow open glottis expirations, huffing and cough) combined with a sham procedure using the Semiox® device, while the intervention group will reveive similar respiratory physiotherapy combined with the Semiox® oscillatory negative-pressure device. Interventions will be carried out once a day by the principal investigator, an experienced physiotherapist, with the agreement of the attending physician.

Interventions

Inclusion criteria

1. Patient with confirmed diagnosis of COPD 2. Hospitalized with respiratory onset 3. With an increase of his usual secretion production

Exclusion criteria

1. Hemodynamic instability requiring vasopressor support 2. Severe respiratory failure defined as PaO₂/FiO₂ < 100 3. Respiratory failure requiring a fraction of inspired oxygen (FiO₂) > 60% 4. Altered level of consciousness or inability to cooperate with the intervention 5. Untreated or undrained pneumothorax 6. Massive hemoptysis 7. Unstable cardiovascular disease (e.g., acute coronary syndrome, uncontrolled arrhythmias) 8. Any clinical condition requiring strict bed rest or contraindicating participation in respiratory physiotherapy

Locations

Related clinical trials

View on source registry